[vc_row][vc_column width=”1/2″][vc_column_text]
Objective Look at Localized Retinal Dysfunction.
As eye care specialists, you frequently co-manage patients with other health care providers such as primary care physicians, rheumatologists, and neurologists. This often makes you the first line of detection when certain medications prescribed by those physicians start negatively impacting the patient’s retina. In some cases, retinal dysfunction may occur without structural abnormalities, requiring a robust functional testing method to detect retinal toxicity early.1-3 Diopsys® mfERG (multifocal electroretinography) vision tests provide you with the objective, functional information you need to help recognize the first signs of drug-induced retinopathy, and work with the other providers to make the best clinical decisions for each patient.
- Objectively monitor function loss and recovery with objective, quantitative metrics1-2
- Co-manage patients more efficiently for more timely changes to treatment
- Clear, intuitive report interpretation
[/vc_column_text][vc_separator][vc_column_text]
Multifocal Electroretinography (mfERG) Vision Testing
Multifocal ERG has been recognized as an effective test in helping doctors to diagnose and manage diseases affecting the retina, most notably retinal toxicities.1-3 This visual electrophysiology technique is a test of localized retinal function through quasi-simultaneous stimulation of different areas of the retina.4 The American Academy of Ophthalmology (AAO) recommends the use of multifocal electroretinography for chloroquine (CQ) and hydroxychloroquine (HCQ) retinopathy screening.3[/vc_column_text][vc_column_text]
[/vc_column_text][vc_empty_space height=”30px”][/vc_column][vc_column width=”1/2″][vc_tta_pageable no_fill_content_area=”1″ active_section=”1″ css_animation=”none” el_class=”product-images-carousel”][vc_tta_section tab_id=”1486250009760-dd4aa602-46bef1e9-28b2″][vc_single_image image=”3511″ img_size=”full” alignment=”center” onclick=”link_image”][vc_column_text el_class=”product-image-caption”]
Diopsys® mfERG / Multifocal ERG Vision Testing
[/vc_column_text][/vc_tta_section][vc_tta_section tab_id=”1486250009842-266efa3b-c1e7f1e9-28b2″][vc_single_image image=”3562″ img_size=”full” onclick=”link_image”][vc_column_text]
Diopsys® mfERG | Multifocal Electroretinography
[/vc_column_text][/vc_tta_section][vc_tta_section tab_id=”1487569525557-fc6fa3ea-ad5c”][vc_single_image image=”3563″ img_size=”full” onclick=”link_image”][vc_column_text]
Diopsys® mfERG / Multifocal ERG Test Result – Healthy Eyes
[/vc_column_text][/vc_tta_section][vc_tta_section tab_id=”1491237908990-30331d10-b146″][vc_single_image image=”3559″ img_size=”full” onclick=”link_image”][vc_column_text]
Diopsys® mfERG / Multifocal ERG Test Result – Plaquenil toxicity
[/vc_column_text][/vc_tta_section][vc_tta_section tab_id=”1491237842746-2ad3bbb6-7455″][vc_single_image image=”3560″ img_size=”full” onclick=”link_image”][vc_column_text]
Technician discussing Diopsys® mfERG Vision Test with Patient
[/vc_column_text][/vc_tta_section][/vc_tta_pageable][/vc_column][/vc_row][vc_row full_width=”stretch_row” el_class=”product-info-accordion-row”][vc_column][vc_column_text]
Resources
Expand sections to view resources.
[/vc_column_text][vc_tta_accordion c_icon=”chevron” c_position=”right” active_section=”false” collapsible_all=”true” el_class=”product-info-accordion”][vc_tta_section title=”Clinical Support” tab_id=”1487532687723-9a0b5d17-0468″][vc_column_text][product-resources product=”diopsys-mferg” resource-type=”clinical-support”][/vc_column_text][/vc_tta_section][vc_tta_section title=”Case Studies” tab_id=”1487532687773-aff84d6c-e9ee”][vc_column_text][product-resources product=”diopsys-mferg” resource-type=”case-study”][/vc_column_text][/vc_tta_section][vc_tta_section title=”Webinars” tab_id=”1487532714500-988cade6-29ec”][vc_column_text][product-resources product=”diopsys-mferg” resource-type=”webinar”][/vc_column_text][/vc_tta_section][vc_tta_section title=”In the News” tab_id=”1487532724417-ea30d6e8-8a37″][vc_column_text][product-resources product=”diopsys-mferg” resource-type=”in-the-news”][/vc_column_text][/vc_tta_section][vc_tta_section title=”Training Videos” tab_id=”1487532735320-0f548355-3b4e”][vc_column_text][product-resources product=”diopsys-mferg” resource-type=”training-video”][/vc_column_text][/vc_tta_section][vc_tta_section title=”Request More Information” tab_id=”request-more-information”][vc_raw_html]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[/vc_raw_html][/vc_tta_section][/vc_tta_accordion][vc_column_text el_class=”additional-information”][/vc_column_text][vc_empty_space height=”30px”][vc_separator color=”custom” accent_color=”#d2dcea”][vc_column_text el_class=”references”]
- Dettoraki M, Moschos MM. The Role of Multifocal Electroretinography in the Assessment of Drug-Induced Retinopathy: A Review of the Literature. Ophthalmic Res 2016;56:169–177
- Talamini CL, et al. Abnormal multifocal ERG findings in patients with normal-appearing retinal anatomy. Doc Ophthalmol 2011;123(3):187-192.
- Marmor, M, et al. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision). Ophthalmology 2016;123:6:1386-1394
- Hood, DC, et al. ISCEV Standard for clinical multifocal electroretinography (2011 edition). Doc Ophthalmol 124:1–13.
[/vc_column_text][/vc_column][/vc_row][vc_row full_width=”stretch_row” el_class=”product-testimonials-row”][vc_column][vc_row_inner][vc_column_inner width=”2/3″][vc_column_text]
Diopsys provides an in-office ERG platform that allows clinicians to establish a functional baseline in diabetic retinopathy, and then follow disease in a way that we can’t otherwise.
In my 40 some years in this business, this is the first time that we’ve been able to get real, objective evidence of how the retina’s doing in a host of conditions.
Now I have a reliable, objective test of retinal function that I can perform pre-operatively to give me an idea of what's going on behind the cataract. Flicker ERG has helped me ensure that these patients are accurately prepared for the outcome of their surgery.
